Research
Our current interests
Our laboratory is driven to discover new ways to improve cancer control and provide scientific rationale for recommendations made in every day oncologic practice. We have particular interest in the following areas: (i) developing novel therapeutic cancer vaccines; (ii) understanding the role and modulation of neutrophil extracellular traps (NETs) in the context of cancer; (iii) characterizing tumor-associated microbes and explore tumor microecology disruption as a therapeutic strategy; (iv) rationalizing chemotherapy tactics; and (v) improving supportive therapies (managing cancer pain and chemotherapy-induced gastrointestinal upset) for companion animals with cancer.
Therapeutic Cancer Vaccines
DC Cancer Vaccine
Metabolic labeling and targeting of dendritic cells (DCs) to enhance DC cancer vaccines
Diverse Therapeutic and Diagnostic Approaches
RBC Labeling and Targeting Technology
Metabolic labeling and targeting of red blood cells (RBCs) for various diagnostic and therapeutic applications
Collaborators
Collaborations are essential to accelerate scientific discoveries. Dr. Berry has active collaborative projects with the following investigators:
Tim Fan
Paul Hergenrother
Hua Wang
Kari Foss
Arnon Gal
